Terms: = Thyroid cancer AND TAF15, hTAFII68, 8148, ENSG00000172660, TAF2N, RBP56, Npl3, Q92804
16 results:
1. Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions.
Lenz J; Klubíčková N; Ptáková N; Hájková V; Grossmann P; Šteiner P; Kinkor Z; Švajdler M; Michal M; Konečná P; Macháčová D; Hurník P; Tichý M; Tichý F; Kyllar M; Fiala L; Kavka M; Michal M
Hum Pathol; 2023 Apr; 134():19-29. PubMed ID: 36563884
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA SNHG4 enhances RNF14 mRNA stability to promote the progression of colorectal cancer by recruiting taf15 protein.
Lv L; Huang B; Yi L; Zhang L
Apoptosis; 2023 Apr; 28(3-4):414-431. PubMed ID: 36482019
[TBL] [Abstract] [Full Text] [Related]
3. A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma.
Ngo C; Verret B; Vibert J; Cotteret S; Levy A; Pechoux CL; Haddag-Miliani L; Honore C; Faron M; Quinquis F; Cesne AL; Scoazec JY; Pierron G
Genes Chromosomes Cancer; 2023 Jan; 62(1):52-56. PubMed ID: 35932215
[TBL] [Abstract] [Full Text] [Related]
4. SMARCA2-NR4A3 is a novel fusion gene of extraskeletal myxoid chondrosarcoma identified by RNA next-generation sequencing.
Wei S; Pei J; von Mehren M; Abraham JA; Patchefsky AS; Cooper HS
Genes Chromosomes Cancer; 2021 Oct; 60(10):709-712. PubMed ID: 34124809
[TBL] [Abstract] [Full Text] [Related]
5. Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group.
Paioli A; Stacchiotti S; Campanacci D; Palmerini E; Frezza AM; Longhi A; Radaelli S; Donati DM; Beltrami G; Bianchi G; Barisella M; Righi A; Benini S; Fiore M; Picci P; Gronchi A
Ann Surg Oncol; 2021 Feb; 28(2):1142-1150. PubMed ID: 32572850
[TBL] [Abstract] [Full Text] [Related]
6. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and taf15 translocated extraskeletal myxoid chondrosarcomas.
Brenca M; Stacchiotti S; Fassetta K; Sbaraglia M; Janjusevic M; Racanelli D; Polano M; Rossi S; Brich S; Dagrada GP; Collini P; Colombo C; Gronchi A; Astolfi A; Indio V; Pantaleo MA; Picci P; Casali PG; Dei Tos AP; Pilotti S; Maestro R
J Pathol; 2019 Sep; 249(1):90-101. PubMed ID: 31020999
[TBL] [Abstract] [Full Text] [Related]
7. HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma.
Urbini M; Astolfi A; Pantaleo MA; Serravalle S; Dei Tos AP; Picci P; Indio V; Sbaraglia M; Benini S; Righi A; Gambarotti M; Gronchi A; Colombo C; Dagrada GP; Pilotti S; Maestro R; Polano M; Saponara M; Tarantino G; Pession A; Biasco G; Casali PG; Stacchiotti S
Genes Chromosomes Cancer; 2017 Jul; 56(7):582-586. PubMed ID: 28383167
[TBL] [Abstract] [Full Text] [Related]
8. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
Broehm CJ; Wu J; Gullapalli RR; Bocklage T
Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955
[TBL] [Abstract] [Full Text] [Related]
9. Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.
Agaram NP; Zhang L; Sung YS; Singer S; Antonescu CR
Hum Pathol; 2014 May; 45(5):1084-91. PubMed ID: 24746215
[TBL] [Abstract] [Full Text] [Related]
10. Activity of sunitinib in extraskeletal myxoid chondrosarcoma.
Stacchiotti S; Pantaleo MA; Astolfi A; Dagrada GP; Negri T; Dei Tos AP; Indio V; Morosi C; Gronchi A; Colombo C; Conca E; Toffolatti L; Tazzari M; Crippa F; Maestro R; Pilotti S; Casali PG
Eur J Cancer; 2014 Jun; 50(9):1657-64. PubMed ID: 24703573
[TBL] [Abstract] [Full Text] [Related]
11. Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes.
Hisaoka M; Okamoto S; Yokoyama K; Hashimoto H
Cancer Genet Cytogenet; 2004 Jul; 152(2):101-7. PubMed ID: 15262426
[TBL] [Abstract] [Full Text] [Related]
12. Molecular genetic characterization of the EWS/CHN and rbp56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.
Panagopoulos I; Mertens F; Isaksson M; Domanski HA; Brosjö O; Heim S; Bjerkehagen B; Sciot R; Dal Cin P; Fletcher JA; Fletcher CD; Mandahl N
Genes Chromosomes Cancer; 2002 Dec; 35(4):340-52. PubMed ID: 12378528
[TBL] [Abstract] [Full Text] [Related]
13. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases.
Okamoto S; Hisaoka M; Ishida T; Imamura T; Kanda H; Shimajiri S; Hashimoto H
Hum Pathol; 2001 Oct; 32(10):1116-24. PubMed ID: 11679947
[TBL] [Abstract] [Full Text] [Related]
14. Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21).
Sjögren H; Wedell B; Meis-Kindblom JM; Kindblom LG; Stenman G
Cancer Res; 2000 Dec; 60(24):6832-5. PubMed ID: 11156374
[TBL] [Abstract] [Full Text] [Related]
15. Identification of a novel fusion gene involving htafii68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma.
Attwooll C; Tariq M; Harris M; Coyne JD; Telford N; Varley JM
Oncogene; 1999 Dec; 18(52):7599-601. PubMed ID: 10602520
[TBL] [Abstract] [Full Text] [Related]
16. Fusion of the EWS-related gene taf2n to TEC in extraskeletal myxoid chondrosarcoma.
Sjögren H; Meis-Kindblom J; Kindblom LG; Aman P; Stenman G
Cancer Res; 1999 Oct; 59(20):5064-7. PubMed ID: 10537274
[TBL] [Abstract] [Full Text] [Related]